Armata Pharmaceuticals, Inc. (ARMP) News
Track canonical SquawkNews coverage tagged to ARMP, Armata Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ARMP Announces Q2 2026 Financial Results
ARMP announces financial results for the second quarter 2026 and provides a corporate update
EARNINGS | Aug 12, 2026, 08:06 PM UTC
L
Armata Pharma Reaches FDA Agreement on Pediatric Study Plan for AP-SA02
() -- Armata Pharmaceuticals (ARMP) said Monday it has reached agreement with the US Food and Drug Administration on an agreed initial pediatric study plan for AP-SA02, clearing a regulatory requirement ahead of a potent
REGULATION | Jul 13, 2026, 11:47 AM UTC
L
Armata Pharmaceuticals reaches agreement with FDA on iPSP for AP-SA02
Armata Pharmaceuticals...
EQUITY | Jul 13, 2026, 11:04 AM UTC
M
ARMP Receives $2.5M Funding
Armata Pharmaceuticals receives $2.5 million in non-dilutive award funding from the U.S. Department of Defense to support AP-SA02
EQUITY | Jun 23, 2026, 11:03 AM UTC